Table 2: Pretreatment manifestations in 25 patients with IGPs.

Pretreatment presentationsPatient number % of patients

Visual change1352
Headache1040
Dizziness14
Hypopituitarism28
Cognitive decline14
Decreased sexual function1372
Amenorrhea571
Galactorrhea229
Nasal obstruction and hemorrhage28
Axillary and pubic hair loss528

In males, the decreased sexual function was 13/18.
In females, the incidence of amenorrhea and galactorrhea was 5/7 and 2/7, respectively.